No Data
No Data
Express News | Immunome Appoints Phil Tsai as Chief Technical Officer
Immunome Initiated at Overweight by Piper Sandler
Immunome Initiated at Overweight by Piper Sandler
Immunome (IMNM.US) was first covered by Piper Sandler, which gave it an increase rating, and the target price was $27.00.
Immunome (IMNM.US) was first covered by Piper Sandler, which gave it an increase rating, and the target price was $27.00.
Piper Sandler Initiates Coverage On Immunome With Overweight Rating, Announces Price Target of $27
Piper Sandler analyst Biren Amin initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price Target of $27.
Immunome Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 87.5% Piper Sandler → $27 Initiates Coverage On → Overweight 04/30/2024 66.67% JP Morgan → $24
Bullish Immunome Insiders Loaded Up On US$2.67m Of Stock
Over the last year, a good number of insiders have significantly increased their holdings in Immunome, Inc. (NASDAQ:IMNM). This is encouraging because it indicates that insiders are more optimistic ab